We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
A review of the latest allergen measurement techniques and an outline of how allergen cases are being dealt with in UK courts.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
We want to know what you think about our proposal to Nasonex Allergy Control Nasal Spray available without prescription.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).